Literature DB >> 8502521

Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying.

D A Blumberg1, K Lewis, C M Mink, P D Christenson, P Chatfield, J D Cherry.   

Abstract

OBJECTIVE: The pathophysiology of severe reactions to diphtheria-tetanus-pertussis (DTP)vaccine is not well understood. Active pertussis toxin in DTP vaccine has been proposed to cause severe DTP vaccine reactions. Large doses of pertussis toxin cause hyperinsulinemia and hypoglycemia as well as leukocytosis with a predominant lymphocytosis in animal models. To learn more about the causes of and risk factors for severe DTP vaccine reactions, children experiencing severe DTP vaccine reactions were studied.
DESIGN: Prospective, referral-based surveillance.
SETTING: Los Angeles, CA.
SUBJECTS: Children experiencing severe reactions within 48 hours of DTP immunization and evaluated within 24 hours of the reaction. Severe reactions included encephalopathy, persistent crying > or = 3 hours, hypotonic-hyporesponsive episodes (collapse episodes), fever > or = 40.5 degrees C, or seizures. Some comparisons were made between children with DTP vaccine-associated seizures and a comparison group of children experiencing febrile seizures unrelated to immunization. OUTCOME MEASURES: A history and physical examination were performed. Follow-up examinations were performed 1 month later. Blood was collected for complete blood cell count with leukocyte differential count, serum chemistry measurements, and insulin and glucose values. Serum was assayed for active pertussis toxin, both in free and immune-complex masked states.
RESULTS: Sixty children experienced severe reactions within 48 hours of DTP immunization: 32 children had seizures only, 14 subjects had hypotonic-hyporesponsive episodes, 2 subjects had fever > or = 40.5 degrees C only, 4 subjects had persistent crying > or = 3 hours, 6 children had seizures and fever > or = 40.5 degrees C, and 2 children had persistent crying and seizures. The children with seizures had a high rate of personal and family histories of seizures, and 90% had documented fevers (> or = 38 degrees C). Persistent crying was associated with painful local reactions. Effects that may have been due to vaccine pertussis toxin were not found. Lymphocytosis did not occur, nor did hypoglycemia. Some relatively elevated insulin values were noted; however, this finding was also noted in the comparison group of children experiencing febrile seizures unrelated to immunization. No biologically active pertussis toxin was found in the acute sera of children experiencing severe DTP vaccine reactions.
CONCLUSIONS: Seizures associated with DTP vaccine have similar clinical characteristics as febrile seizures, and persistent crying is initiated by painful local reactions. Vaccine endotoxin is a cause of febrile DTP vaccine reactions. We found no evidence that DTP vaccine pertussis toxin plays a role in severe DTP vaccine reactions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8502521

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

Review 1.  An overview of the status of acellular pertussis vaccines in practice.

Authors:  A L Lopez; D A Blumberg
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 2.  Pertussis and Rotavirus Vaccines - Controversies and Solutions.

Authors:  Nabaneeta Dash; Sanjay Verma
Journal:  Indian J Pediatr       Date:  2017-06-16       Impact factor: 1.967

Review 3.  Hypotonic-hyporesponsive episodes following pertussis vaccination: a cause for concern?

Authors:  Michael S Gold
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination.

Authors:  S Donnelly; C E Loscher; M A Lynch; K H Mills
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  Monokine production following in vitro stimulation of the THP-1 human monocytic cell line with pertussis vaccine components.

Authors:  J Blood-Siegfried; E Crabb Breen; S Takeshita; O Martinez-Maza; D Vredevoe
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

6.  Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice.

Authors:  I P Nascimento; W O Dias; R P Mazzantini; E N Miyaji; M Gamberini; W Quintilio; V C Gebara; D F Cardoso; P L Ho; I Raw; N Winter; B Gicquel; R Rappuoli; L C Leite
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

7.  Analysis of the role of Bphs/Hrh1 in the genetic control of responsiveness to pertussis toxin.

Authors:  Jian Feng Gao; Stanford B Call; Parley D Fillmore; Takeshi Watanabe; Nathan D Meeker; Cory Teuscher
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

8.  Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model.

Authors:  Darren P Ennis; Joseph P Cassidy; Bernard P Mahon
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

Review 9.  Febrile seizures.

Authors:  Sajun Chung
Journal:  Korean J Pediatr       Date:  2014-09-30

10.  Emerging Bordetella pertussis Strains Induce Enhanced Signaling of Human Pattern Recognition Receptors TLR2, NOD2 and Secretion of IL-10 by Dendritic Cells.

Authors:  Elise S Hovingh; Marjolein van Gent; Hendrik-Jan Hamstra; Marc Demkes; Frits R Mooi; Elena Pinelli
Journal:  PLoS One       Date:  2017-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.